Filters
Other countries
Results: 1 to 16 of 16
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Tempus Labs, Inc. United States | 2 | 647 |
|
Otogenetics Hereditary Cancers Otogenetics United States | 36 | 39 |
|
Ambry Genetics United States | 79 | 80 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Ambry Genetics United States | 147 | 91 |
|
PreventionGenetics, part of Exact Sciences United States | 27 | 18 |
|
PreventionGenetics, part of Exact Sciences United States | 122 | 117 |
|
Pancreatic cancer (WES based NGS panel of 26 genes, including analysis of CNVs) CGC Genetics Unilabs Portugal | 1 | 26 |
|
Pancreatic cancer, susceptibility to, 1 (P239S mutation on PALLD gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Laboratorio de Genetica Clinica SL Spain | 1 | 249 |
|
Genomic Unity® Custom Analysis Variantyx, Inc. United States | 1 | 4054 |
|
Known Familial Copy Number Variant(s) GeneDx United States | 1 | 45 |
|
CEN4GEN Comprehensive Hereditary Cancer Syndrome: Gene sequencing Panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 1 | 143 |
|
Fulgent Genetics United States | 3 | 1 |
|
CeGaT GmbH Germany | 6 | 17 |
|
Fulgent Genetics United States | 5129 | 4672 |
|
Results: 1 to 16 of 16
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.